Publication | Closed Access
Tenofovir alafenamide and elvitegravir loaded nanoparticles for long-acting prevention of HIV-1 vaginal transmission
49
Citations
25
References
2016
Year
This proof-of-concept study demonstrated sustained protection for TAF + EVG nanoparticles in a hu-BLT mouse model of HIV vaginal transmission.
| Year | Citations | |
|---|---|---|
Page 1
Page 1